Scoopfeeds — Intelligent news, curated.
Cizzle Biotechnology receives U.S. patent for lung cancer test
business

Cizzle Biotechnology receives U.S. patent for lung cancer test

Investing.com · Jun 12, 2026, 6:19 AM

Cizzle Biotechnology receives U.S. patent for lung cancer test

Read full story on Investing.com → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop